Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry

World Journal of Gastroenterology

Volumn 12, Issue 10, 2006, Pages 1536-1544

  Engwegen, Judith Y M N ^a   Helgason, Helgi H ^b   Cats, Annemieke ^b   Harris, Nathan ^c   Bonfrer, Johannes M G ^b   Schellens, Jan H M ^b,d   Beijnen, Jos H ^a,d  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c Ciphergen Biosystem Inc   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Biomarker; Colorectal cancer; Proteomics; Sensitivity; Specificity

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN C1; BIOLOGICAL MARKER; BUFFER; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CATION; TRANSFERRIN;

ALGORITHM; AMINO TERMINAL SEQUENCE; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CLASSIFICATION; COLORECTAL CANCER; CONTROLLED STUDY; DATA ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PH; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 33645729811     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i10.1536     Document Type: Article

References (33)

1. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004; 351: 2704-2714
2. Duffy Mj. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001; 47: 624-630
3. AhIquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and Hemo-Quant tests. JAMA 1993; 269:1262-1267
4. Greenberg PD, Bertario L, Gnauck R, Kronborg O, Hardcastle JD, Epstein MS, Sadowski D, Sudduth R, Zuckerman GR, Rockey DC. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 2000; 95: 1331-1338
5. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003; 39: 718-727
6. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR. 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1865-1878
7. Issaq Hj, Veenstra TD, Conrads TP, Felschow D. The SELDITOF MS approach to proteomics: protein profilingand biomarker identification. Biochem Biophys Res Commun 2002; 292: 587-592
8. Graves PR, Haystead TA. Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 2002; 66: 39-63; table of contents
9. Adam BL, Qu Y, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright GL Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002; 62: 3609-3614
10. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-577
11. Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry. Lung Cancer 2003; 40: 267-279
12. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW. Proteonmics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48: 1296-1304
13. Shiwa M, Nishimura Y, Wakatabe R, Fukawa A, Arikuni H, Ota H, Kato Y, Yamori T. Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform. Biochem Biophys Res Commun 2003; 309:18-25
14. Krieg RC, Fogt F, Braunschweig T, Herrmann PC, Wollscheidt V, Wellmarm A. ProteinChip Array analysis of microdissected colorectal carcinoma and associated tumor stroma. shows specific protein bands in the 3.4 to 3.6 kDa range. Anticancer Res 2004; 24: 1791-1796
15. Wang YY, Zhang Z, White N, Rosenzweig J, Li J, Shih I, Sokoll LJ, Chan DW. Detection of cancer biomarkers by SELDI proteomics technology from serum in colorectal carcinoma. Proc Amer Assoc Cancer Res 2003; 44:
16. Zhao G, Gao CF, Song GY, Li DH, Wang XL. Identification of colorectal cancer using proteomic patterns in serum. Ai Zheng 2004; 23: 614-618
17. Yu JK, Chen YD, Zheng S. An integrated approach to the detection of colorectal cancer utilizing proteornics and bioinformatics. World J Gastroenterol 2004; 10: 3127-3131
18. Chen YD, Zheng S, Yu JK, Hu X. Artificial neural networks analysis of surf ace-enhanced laser desorption/ ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 2004; 10: 8380-8385
19. Gast MCK Bonfrer JMG, Rutgers E, Schellens JHM, Beijnen JH. Proteomics in patients with breast cancer: unique profile discriminates patients from matched controls: Proceedings of the Dutch Society for Clinical Pharmacology and Biopharmacy, 16 April 2004. Br J Clin Pharmacol 2005; 59: 123-139
20. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipo-protein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vase Biol 1999; 19: 472-484
21. Allard L, Lescuyer P, Burgess J, Leung KY, Ward M, Walter N, Burkhard PR, Corthals G, Hochstrasser DF, Sanchez JC. ApoC-1 and ApoC-111 as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 2004; 4: 2242-2251
22. Steel LF, Shumpert D, Trotter M, Seeholzer SH, Evans AA, London WT, Dwek R, Block TM. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 2003; 3: 601-609
23. Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003; 18: 505-509
24. Wang Z, Yip C, Ying Y, Wang J, Meng XY, Lomas L, Yip TT, Fung ET. Mass spectrometric analysis of protein markers for ovarian cancer. Clin Chem 2004; 50:1939-1942
25. Zhang Z, Bast RC Jr, Yu Y, Li J, Sokoll LJ, Rai AJ, Rosenzweig JM, Cameron B, Wang YY, Meng XY, Berchuck A, Van Haaf-ten-Day C, Hacker NF, de Bruijn HW, van der Zee AG, Jacobs IJ, Fung ET, Chan DW. Three biomarkers identified from serum proteornic analysis for the detection of early stage ovarian cancer. Cancer Res 2004; 64: 5882-5890
26. Tachibana M, Ohkura Y, Kobayashi Y, Sakamoto H, Tanaka Y, Watanabe J, Amikura. K, Nishimura Y, Akagi K. Expression of apolipoprotein Al in colonic adenocarcinoma. Anticancer Res 2003; 23: 4161-4167
27. He QY, Lau GK, Zhou Y, Yuen ST, Lin MC, Kung HF, Chiu JF. Serum biomarkers of hepatitis B virus infected liver inflammation: a proteomic study. Proteomics 2003; 3: 666-674
28. Puchades M, Hansson SF, Nilsson CL, Andreasen N, Blennow K, Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 2003; 118: 140-146
29. Dayal B, Ertel NH. ProteinChip technology: a new and facile method for the identification and measurement of high-density lipoproteins apoA-I and apoA-11 and their glycosylated products in patients with diabetes and cardiovascular disease. J Proteome Res 2002; 1: 375-380
30. Mateos-Caceres PJ, Garcia-Mendez A, Lopez Farre A, Macaya C, Nunez A, Gomez J, Alonso-Orgaz S, Carrasco C, Burgos ME, de Andres R, Granizo JJ, Farre J, Rico LA. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 2004; 44: 1578-1583
31. Chen W, Ji J, Xu X, He S, Ru B. Proteomic comparison between human young and old brains by two-dimensional gel electrophoresis and identification of proteins. Int J Dev Neurosci 2003; 21: 209-216
32. Garbett EA, Reed MW, Brown NJ. Proteolysis in colorectal cancer. Mol Pathol 1999; 52: 140-145
33. Kim SB, Fernandes LC, Saad SS, Matos D. Assessment of the value of preoperative serum levels of CA 242 and CEA in the staging and postoperative survival of colorectal adenocarcinoma patients. Int J Biol Markers 2003; 18: 182-187